Related Articles |
Immune Mechanisms and Novel Targets in Rheumatoid Arthritis.
Immunol Allergy Clin North Am. 2017 May;37(2):301-313
Authors: Venuturupalli S
Abstract
Significant progress has been made in understanding the pathophysiology of rheumatoid arthritis. It is widely recognized that early institution of treatment is one of the best predictive factors for response to therapy. Several novel approaches are currently being investigated and several novel biologics are in various stages of development. With advances in the fields of proteomics, genomics, and metabolomics, specific phenotypes of the disease can be better identified and specific therapies for particular phases of the disease and specific patients will allow for improved control of this condition.
PMID: 28366478 [PubMed - in process]
http://ift.tt/2oGtxQO
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου